Related Experiment Videos
Autoimmune hepatitis: evolving concepts
Ioannis Diamantis1, Dimitrios T Boumpas
1Department of Internal Medicine and Division of Rheumatology, Clinical Immunology and Allergy, Medical School, University of Crete, P.O. Box 2208, Heraklion GR-71003, Greece. idiamant@med.uoc.gr
Autoimmunity Reviews
|April 28, 2004
Summary
Autoimmune hepatitis (AIH) involves a loss of immune tolerance to liver antigens, leading to T cell attacks on liver cells. Understanding these self-antigens is key to developing targeted AIH therapies.
Area of Science:
- Hepatology
- Immunology
- Autoimmunity
Background:
- The liver faces constant exposure to diverse antigens, including pathogens, toxins, and dietary components.
- Autoimmune hepatitis (AIH) arises from a breakdown in immune tolerance towards self-antigens within the liver.
- The exact triggers for AIH remain elusive but involve genetic susceptibility and environmental factors.
Purpose of the Study:
- To identify and characterize hepatocellular surface antigens targeted in autoimmune hepatitis.
- To understand the immunological mechanisms underlying liver injury in AIH.
Main Methods:
- Identification of autoantibodies and their corresponding liver antigens.
- Analysis of T cell responses to autologous liver antigens in AIH patients.
Main Results:
- Several autoantibodies (anti-LKM-1, anti-SMA, anti-LP, anti-LC1) recognize specific liver antigens, including P450-IID6, asialoglycoprotein receptor, and others.
- AIH patients exhibit heightened T cell reactivity against their own liver antigens compared to other chronic hepatitis patients.
Conclusions:
- Specific liver antigens are recognized by autoantibodies in AIH, indicating a targeted autoimmune response.
- T cell-mediated immunity plays a crucial role in the liver tissue injury observed in autoimmune hepatitis.